BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » News » Publication » New findings about the molecular mechanisms behind the deterioration in β-cell function

New findings about the molecular mechanisms behind the deterioration in β-cell function

The results from new findings about the molecular mechanisms behind the age-dependent deterioration in β-cell function have been published in Advances in Biological Regulation (formerly Advances in Enzyme Regulation); a journal reporting cutting edge scientific progress on regulation at the molecular level.

Defects in pancreatic β-cell function and survival are key components in type 2 diabetes. Though the molecular mechanisms behind the age-dependent deterioration in β-cell function are not fully understood, our previous studies have indicated that the regulation of cytoplasmic free Ca(2+) concentration may be critical and dependent on the proper function of the mitochondria. By the use of three mouse models, we have been able to present data which suggest that even relatively small, time-dependent changes in β-cell signal-transduction result in compromised insulin release in a diabetic phenotype.

Read more:    β-Cell Ca(2+) dynamics and function are compromised in aging. Christopher Barker, L. Li, Martin Köhler, Per-Olof Berggren. Advances in Biological Regulation. January 2015.

September 2, 2020 Catharina Rahm

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications February 6, 2025
  • Årsstämma 17 juni 2024
    Årsstämma 17 juni 2024 June 2, 2024
  • Researchers use the eye as a window to study liver health
    Researchers use the eye as a window to study liver health February 8, 2024
  • ERC Proof of Concept to Professor Per-Olof Berggren
    ERC Proof of Concept to Professor Per-Olof Berggren February 7, 2024
  • The anterior chamber of the eye as a servant to medical research in translation
    The anterior chamber of the eye as a servant to medical research in translation February 7, 2024
  • Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize
    Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize February 7, 2024
  • Eye implant may be used to treat diabetes
    Eye implant may be used to treat diabetes February 7, 2024
  • Årsstämma 16 juni 2023
    Årsstämma 16 juni 2023 May 29, 2023
  • New strategy to preserve insulin-producing cells in diabetes
    New strategy to preserve insulin-producing cells in diabetes August 19, 2022
  • Kallelse till årsstämma 27 juni 2022
    Kallelse till årsstämma 27 juni 2022 June 6, 2022

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved